roxatidine acetate has been researched along with Gastric Ulcer in 14 studies
roxatidine acetate: structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 9.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
"The effects of IGN-2098 on the healing process of acetic acid-induced gastric ulcer was investigated in comparison with the other histamine H2-receptor antagonists, famotidine and roxatidine acetate HCl, in rats." | 7.69 | [Therapeutic effect of IGN-2098, a new antiulcer drug (H2-antagonist), in the ulcer diminishing period against acetic acid-induced gastric ulcer in rats]. ( Ikarashi, Y; Misaki, N; Ohba, S; Ohbayashi, S; Uchida, M, 1995) |
"This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 5.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
"The effects of IGN-2098 on the healing process of acetic acid-induced gastric ulcer was investigated in comparison with the other histamine H2-receptor antagonists, famotidine and roxatidine acetate HCl, in rats." | 3.69 | [Therapeutic effect of IGN-2098, a new antiulcer drug (H2-antagonist), in the ulcer diminishing period against acetic acid-induced gastric ulcer in rats]. ( Ikarashi, Y; Misaki, N; Ohba, S; Ohbayashi, S; Uchida, M, 1995) |
"Healing-promoting actions of KU-1257 (N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea, CAS 120958-90-9) were investigated in chronic gastric and duodenal ulcer models induced by acetic acid in rats and the effects were compared with those of famotidine and roxatidine acetate by gross or histological evaluation." | 3.68 | Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats. ( Aijima, H; Hamada, K; Nishino, K; Sekiguchi, H; Taga, F; Uchida, H, 1993) |
"Omeprazole is an inhibitor of gastric H+,K(+)-ATPase." | 1.29 | Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. ( Abe, K; Furukawa, Y; Katano, K; Mizunashi, K, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 11 (78.57) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsura, Y | 1 |
Inoue, Y | 1 |
Tomishi, T | 1 |
Ishikawa, H | 1 |
Takasugi, H | 1 |
Imaeda, H | 1 |
Hosoe, N | 1 |
Suzuki, H | 1 |
Saito, Y | 1 |
Ida, Y | 1 |
Nakamura, R | 1 |
Iwao, Y | 1 |
Ogata, H | 1 |
Hibi, T | 1 |
Fujino, MA | 1 |
Morozumi, A | 1 |
Kobayashi, K | 1 |
Ueda, F | 1 |
Suzuki, Y | 1 |
Uchida, N | 1 |
Tachikawa, H | 1 |
Sano, S | 1 |
Ohtsuka, H | 1 |
Yamamoto, Y | 1 |
Uchida, M | 1 |
Ikarashi, Y | 1 |
Ohba, S | 1 |
Ohbayashi, S | 1 |
Misaki, N | 2 |
Müller, P | 1 |
Jackisch, P | 1 |
Simon, B | 1 |
Tanaka, M | 2 |
Maruoka, A | 1 |
Chijiiwa, Y | 1 |
Nawata, H | 1 |
Sekiguchi, H | 1 |
Hamada, K | 1 |
Aijima, H | 1 |
Taga, F | 1 |
Uchida, H | 1 |
Nishino, K | 1 |
Mizunashi, K | 1 |
Furukawa, Y | 1 |
Katano, K | 1 |
Abe, K | 1 |
Ivanov, C | 1 |
Petkov, O | 1 |
Petrov, P | 1 |
Taskov, M | 1 |
Athanassova, R | 1 |
Tsvetkova, E | 1 |
Kotsev, V | 1 |
Lyutakov, G | 1 |
Nikolov, G | 1 |
Savov, E | 1 |
Horiuchi, Y | 1 |
Katagiri, T | 1 |
Kawamura, T | 1 |
Miyaji, C | 1 |
Toyabe, S | 1 |
Fukuda, M | 1 |
Watanabe, H | 1 |
Abo, T | 1 |
Okabe, S | 2 |
Narita, M | 1 |
Nakaji, S | 1 |
Takinami, Y | 1 |
Kawano, O | 1 |
Takagi, K | 1 |
Igata, H | 1 |
Kato, S | 1 |
Shimosako, K | 1 |
Yamaji, Y | 1 |
Seiki, M | 1 |
Dammann, HG | 1 |
de Looze, SM | 1 |
Bender, W | 1 |
Labs, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Correlation Between Peri-implantitis and Assumptions of Medications: a Retrospective Study[NCT04783974] | 270 participants (Actual) | Observational | 2021-02-15 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for roxatidine acetate and Gastric Ulcer
Article | Year |
---|---|
Clinical characteristics of roxatidine acetate: a review.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans | 1988 |
4 trials available for roxatidine acetate and Gastric Ulcer
Article | Year |
---|---|
Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cost-Benefit An | 2011 |
Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal | 1995 |
[Comparison of the protective effects of roxatidine and misoprostol on diclofenac gastroduodenal pathology. An endoscopic, controlled study of volunteers].
Topics: Adult; Anti-Ulcer Agents; Delayed-Action Preparations; Diclofenac; Gastric Acid; Gastroscopy; Histam | 1994 |
Clinical characteristics of roxatidine acetate: a review.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans | 1988 |
10 other studies available for roxatidine acetate and Gastric Ulcer
Article | Year |
---|---|
Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Blood Flow Velocity; Dogs; Gastric Acid; Gastric Mucosa; Guanid | 1994 |
[Therapeutic effect of IGN-2098, a new antiulcer drug (H2-antagonist), in the ulcer diminishing period against acetic acid-induced gastric ulcer in rats].
Topics: Acetates; Acetic Acid; Animals; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Male; Piper | 1995 |
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastros | 1994 |
Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Topics: Acetates; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Famotidine; | 1993 |
Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Biomarkers; Body Weight; Bone Resorption; Calcium; Ch | 1993 |
Synthesis, gastroprotective, antisecretory and anti-Helicobacter effect of N-[3-(3-(1-piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex (MX1)-MX1.
Topics: Animals; Anti-Ulcer Agents; Ethanol; Female; Gastric Mucosa; Helicobacter pylori; Histamine; Male; M | 1996 |
Lichenoid eruptions due to the H2-receptor antagonists roxatidine and ranitidine.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Eruptions; Female; Histamine H2 Antagonists; Humans | 1996 |
Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Animals; Anti-Ulcer Agents; Depression, Chemical; Gr | 2000 |
[Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Juice; Histami | 1992 |
Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Topics: Acetamides; Administration, Oral; Animals; Dogs; Duodenum; Female; Gastric Acid; Gastric Mucosa; His | 1992 |